ArticleScientific reports2026

Integrated platform for linezolid combinations against rifampicin-resistant Mycobacterium tuberculosis: synergy, macrophage apoptosis, and immune modulation.

Dan Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.